LIONS BAY CAPITAL INC (LBI.CA)

CA5362631064 - Common Stock

0.02  -0.01 (-33.33%)

Fundamental Rating

1

Overall LBI gets a fundamental rating of 1 out of 10. We evaluated LBI against 0 industry peers in the Unkown industry. LBI has a bad profitability rating. Also its financial health evaluation is rather negative. LBI has a expensive valuation and it also scores bad on growth.



0

1. Profitability

1.1 Basic Checks

LBI had negative earnings in the past year.
LBI had a negative operating cash flow in the past year.
In the past 5 years LBI reported 4 times negative net income.
In multiple years LBI reported negative operating cash flow during the last 5 years.

1.2 Ratios

Industry RankSector Rank
ROA -42.85%
ROE -67.71%
ROIC N/A
ROA(3y)-40.42%
ROA(5y)-16.88%
ROE(3y)-53.88%
ROE(5y)-24.67%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

LBI's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of LBI has declined.
LBI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3Y14.19%
OM growth 5Y-2.98%
PM growth 3Y22.58%
PM growth 5Y-1.52%
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, LBI has about the same amount of shares outstanding.
Compared to 5 years ago, LBI has more shares outstanding
The debt/assets ratio for LBI has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -1.78, we must say that LBI is in the distress zone and has some risk of bankruptcy.
LBI has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z -1.78
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 1.42 indicates that LBI should not have too much problems paying its short term obligations.
LBI has a Quick Ratio of 1.42. This is a normal value and indicates that LBI is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.42

1

3. Growth

3.1 Past

LBI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.94%, which is quite impressive.
Looking at the last year, LBI shows a very strong growth in Revenue. The Revenue has grown by 45.19%.
EPS 1Y (TTM)27.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.55%
Revenue 1Y (TTM)45.19%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%94.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

LBI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for LBI!.
Industry RankSector Rank
Dividend Yield N/A

LIONS BAY CAPITAL INC

TSX-V:LBI (12/24/2024, 7:00:00 PM)

0.02

-0.01 (-33.33%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners63.76%
Ins Owner ChangeN/A
Market Cap2.84M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.84
P/tB 0.84
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS-0.01
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -42.85%
ROE -67.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-40.42%
ROA(5y)-16.88%
ROE(3y)-53.88%
ROE(5y)-24.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y14.19%
OM growth 5Y-2.98%
PM growth 3Y22.58%
PM growth 5Y-1.52%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover-0.26
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 1.42
Altman-Z -1.78
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.55%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)45.19%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%94.43%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y37.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-185.01%
FCF growth 3YN/A
FCF growth 5Y-9.31%
OCF growth 1Y-196.08%
OCF growth 3YN/A
OCF growth 5Y-9.31%